Article info

PDF
Extended report
Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts

Authors

  • Ye He Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USADepartment of Dermatology, The Second Xiangya Hospital, Central South University, Changsha, China PubMed articlesGoogle scholar articles
  • Pei-Suen Tsou Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA PubMed articlesGoogle scholar articles
  • Dinesh Khanna Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA PubMed articlesGoogle scholar articles
  • Amr H Sawalha Division of Rheumatology, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USACenter for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Amr H Sawalha, Center for Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA; asawalha{at}umich.edu
View Full Text

Citation

He Y, Tsou P, Khanna D, et al
Methyl-CpG-binding protein 2 mediates antifibrotic effects in scleroderma fibroblasts

Publication history

  • Received January 15, 2018
  • Revised April 19, 2018
  • Accepted April 21, 2018
  • First published May 14, 2018.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.